Blepha EyeBag® | Warming Eye Mask | Relief of Dry, Tired and Sore Eyes | Microwaveable | Previously the MGDRx® EyeBag

Product Information

Blepha EyeBag® is an easy-to-use and pleasant warming mask that can be used daily to make the eyes feel more comfortable. The EyeBag® can be used as a treatment for sore gritty eyes, dry eye syndrome, Meibomian Gland Dysfunction, Chalazion treatment, Stye treatment and Blepharitis treatment.

Probing improved meibum lipid levels as measured with a meibometer as well as reduced meibum viscosity

IPL plus MGX improved lid margin vascularity, meibum expressibility and quality in the lower eyelid, and ocular symptoms (OSDI) for up to 12months after treatment Despa F, Orgill DP, Neuwalder J, Lee RC. The relative thermal stability of tissue macromolecules and cellular structure in burn injury. Burns. 2005;31(5):568–77. Square G. Scottish Intercollegiate Guidelines Network SIGN 50. A guideline developer's handbook. SIGN, Edinburgh;2008. Improved ocular symptoms and tear film stability, and reduced acinar diameter and area as detected by in vivo confocal microscopy Maskin SL, Alluri S. Meibography guided intraductal meibomian gland probing using real-time infrared video feed. Br J Ophthalmol. 2020

Remove Blepha EyeBag® from the box and place it on a clean, dry microwaveable plate. Always make certain the dish or plate you use is completely clean as any small food residue can become very hot and these “hot spots” might cause small burns in the Blepha EyeBag® material. The Eye-ssential ® Mask (Thera Pearl, USA) produces warmth when the pearls inside the mask absorb, hold and deliver the heat acquired in the microwave. The mask reaches its peak temperature (38.7 °C) after 3 min and decreases to 37.9 °C after 12 min [ 16]. Stonecipher K, Abell TG, Chotiner B, Chotiner E, Potvin R. Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction. Clin Ophthalmol. 2019;13:993–9.The MiBo Thermoflo ® (Mibo Medical Group, USA) consists of a tactile power console and a wired metal eye pad. The eye pad is heated (temperature not reported) and applied on the closed eyelids along with an ultrasound gel. There is only one case report (III) indicating that an increase in the temperature of the inner surface of the eyelids was not found after 12 min of the MiBoFlo eye pad application [ 24]. Therefore, further studies to prove the effectiveness of this device are required. According to the ‘International Workshop on Meibomian Gland Dysfunction’ [ 1], MGD is classified into two categories based on the meibum: low-delivery and high-delivery states. Low-delivery states are further divided into hyposecretory and obstructive conditions, the obstructive being the most prevalent type. Obstructive MGD is characterized by chemical changes in the meibum or terminal duct obstruction. Hyposecretory MGD is defined by a reduced release of meibum without MG obstruction. A high-delivery state or hypersecretory MGD is characterized by the presence of a large volume of lipids on the lid margin [ 1]. Eyelid temperatures, NITBUT, and TFLLT increased significantly from baseline in test eyes immediately after removal of the heated eyebag compared with those in control eyes (maximum temperature change, 2.3 ± 1.2 °C vs. 0.3 ± 0.5 °C, F = 20.533, p < 0.001; NITBUT change, 4.0 ± 2.3 seconds vs. 0.4 ± 1.7 seconds, p < 0.001; TFLLT change, 2.0 ± 0.9 grades vs. 0.1 ± 0.4 grades, Z = -4.035, p < 0.001). After 10 minutes, measurements remained significantly higher than those in controls (maximum temperature change, 1.0 ± 0.7 °C vs. 0.1 ± 0.3 °C, F = 14.247, p < 0.001; NITBUT change, 3.6 ± 2.1 seconds vs. 0.1 ± 1.9 seconds, p < 0.001; TFLLT change, 1.5 ± 0.9 vs. 0.2 ± 0.5 grades, Z = -3.835, p < 0.001). No adverse events occurred during the study.

Finis D, König C, Hayajneh J, Borrelli M, Schrader S, Geerling G. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea. 2014;33(12):1265–70. The TearCare ® System (Sight Sciences, USA) is an electrothermal controller that heats both eyelids to 41–45 °C by adjusting them with a flexible, single-use material called iLid™. The system encourages meibum expression through normal blinking during the treatment and through the subsequent manual MG expression—the set includes a disposable EXPRESS™ Forceps to perform the manoeuvre. Badawi et al. [ 22, 23] performed a clinical trial (I) evaluating the effectiveness of the TearCare ® System and the MGDRx EyeBag ® in two different groups of MGD patients. While one group underwent the TearCare ® for 12 min and subsequent MG expression, the other group self-applied 5 min of daily therapy with EyeBag ® for 4 weeks. The TearCare ® group showed a higher improvement in signs, including MG scores, and symptoms. Additionally, the effects lasted for 6 months, and no adverse events were reported.

Far East

Li D, Bin LS, Cheng B. Intense pulsed light: from the past to the future. Photomed Laser Surg. 2016;34:435–47 (Mary Ann Liebert Inc.).